

Please try another search
Investing.com - Heron Therapeuti (NASDAQ: HRTX) reported first quarter EPS of $-0.27, $0.01 better than the analyst estimate of $-0.28. Revenue for the quarter came in at $29.62M versus the consensus...
Heron Therapeutics (NASDAQ:HRTX), Inc. (HRTX) ("Heron" or the "Company"), a commercial-stage biotechnology company focused on improving the lives of patients by developing and commercializing...
After-Hours Movers: Scholastic Corp (NASDAQ:SCHL) 13% LOWER; reported Q3 EPS of ($0.57), versus ($0.44) reported last year. Revenue for the quarter came in at $324.9 million, versus $344.5M reported...
By Oliver Gray Investing.com - U.S. stock futures were slightly higher during Thursday's evening trade, extending gains made in the regular session as investors digested the Fed's 25 basis point rate...
Investing.com - Heron Therapeuti (NASDAQ: HRTX) reported first quarter EPS of $-0.17, $0.15 better than the analyst estimate of $-0.32. Revenue for the quarter came in at $30.03M versus the consensus...
Investing.com - Heron Therapeuti reported on Tuesday third quarter earnings that beat analysts' forecasts and revenue that fell short of expectations. Heron Therapeuti announced earnings per share...
Heron Therapeutics (NASDAQ:HRTX) reported Q1 EPS of ($0.63), $0.15 worse than the analyst estimate of ($0.48). Revenue for the quarter came in at $22.4 million versus the consensus estimate of $22.61...
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review